Biosimilars are surging, but their manufacturers’ strategic approaches are diverging.A KIS report says Korea’s top biosimilar ...

Welt announced on Monday that it will unveil ZolipZ, a new treatment concept called “AI-integrated pharmaceuticals” that ...

Kakao Healthcare said Monday that it has rolled out three new features in its AI-powered health management app, PASTA.PASTA ...

The National Cancer Center (NCC) announced Monday that a research team led by Dr. Yoon Kyung-sil from the Cancer Metastasis ...

Professor Lee Jung-yun, an obstetrics and gynecology specialist from Yonsei University College of Medicine, has been named co ...

Childhood and adolescent cancer survival rates have greatly improved, surpassing 90 percent for some types. However, urgent ...

Amid expectations and concerns about the Regional Doctor System to be implemented in 2027, the Lee Jae Myung administration ...

Celltrion announced Monday that it has received the U.S. FDA’s clearance to begin a phase 1 study of CT-P72 (also called ...

ABL Bio received upfront and equity payments from Eli Lilly following the U.S. antitrust review of its Grabody platform ...

Research shows psychiatrists are highly aware of digital therapeutic devices (DTx) for mental health, but actual use remains ...

International health is often perceived merely as "providing medical support overseas," a view that overlooks its ...

UCB Korea said Monday that its dual interleukin-17A and 17F inhibitor, Bimzelx Autoinjector Injection (bimekizumab), has received simultaneous approval from the Ministry of Food and Drug Safety (MFDS) ...